Long-term survival after significant treatment reduction in a patient with CBF-AML

2011-02-01

Pediatric Blood & Cancer , Volume 56 - Issue 2 p. 325- 326

Additional Metadata
Persistent URL	doi.org/10.1002/pbc.22854, hdl.handle.net/1765/34534
Journal	Pediatric Blood & Cancer
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Driessen, E.M.C, van der Velden, V.H.J, Catsman-Berrevoets, C.E, van den Heuvel-Eibrink, M.M, & Beishuizen, A. (2011). Long-term survival after significant treatment reduction in a patient with CBF-AML. Pediatric Blood & Cancer, 56(2), 325–326. doi:10.1002/pbc.22854

Publication